Inhibitory effects of anticancer peptide from Mercenaria on the BGC-823 cells and several enzymes.

An anti-cancer peptide was purified from the Mercenaria (Meretrix meretrix Linnaeus) by the method of chromatography on Sephadex G-25 and FPLC, and its molecular weight was determined to be 3147 Da by the way of MALDI-TOF mass spectrum. The effects of this peptide on human gastric gland carcinoma cells (BGC-823) and their cytoskeletal morphology were investigated. The results showed that the peptide could inhibit the proliferation of BGC-823 cells and obviously destroy the skeletal structures of the cells. When the concentration of the peptide reached 4.0 microg/ml, the inhibition percentage of the cell growth was about 60%. The effects of this anticancer peptide on the activities of superoxide dismutase (SOD), alkaline phosphatase (ALP) and tyrosinase were studied. The results showed that the peptide activated ALP and SOD, but inhibit the tyrosinase activity. When the concentration of the peptide reached to 0.5 microg/ml, the relative activities of SOD, ALP and tyrosinase were determined to be 188.5%, 122.0% and 27.5%, respectively.
AuthorsBo Leng, Xiao-Dan Liu, Qing-Xi Chen
JournalFEBS letters (FEBS Lett) Vol. 579 Issue 5 Pg. 1187-90 (Feb 14 2005) ISSN: 0014-5793 [Print] Netherlands
PMID15710411 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Peptides
  • Monophenol Monooxygenase
  • Superoxide Dismutase
  • Alkaline Phosphatase
  • Alkaline Phosphatase (metabolism)
  • Animals
  • Antineoplastic Agents (isolation & purification, pharmacology)
  • Cell Line, Tumor
  • Enzyme Inhibitors (isolation & purification, pharmacology)
  • Humans
  • Molecular Weight
  • Mollusca (chemistry)
  • Monophenol Monooxygenase (antagonists & inhibitors, metabolism)
  • Peptides (isolation & purification, pharmacology)
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
  • Superoxide Dismutase (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: